Arovella Therapeutics Share Price and Company Fundamentals
Last traded: Today at 4:57 AM
Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer and conditions that affect the central nervous system in Australia and internationally. Its product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; invariant natural killer T (iNKT), a cell therapy platform to treat blood cancer; OroMist, an oro-mucosal technology that delivers a range of drug classes through the cheeks, gums, tongue, or floor of the mouth; and Anagrelide to treat cancer. The company also develops oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy. It has a collaborative research agreement with Imperial College London. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is headquartered in Osborne Park, Australia.
|Primary activities||Development and commercialisation of pharmaceutical products through new methods of delivery.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||55 Howe Street Level 1 Unit 12 Osborne Park WA 6017 Australia|
|Phone / Fax||61 8 6142 5555 /|
|Share registry||AUTOMIC REGISTRY SERVICES|
Arovella Therapeutics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ALA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
ALA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Oct 2022, following are the company executives and directors listed on Arovella Therapeutics.
|Dr. Michael Baker||CEO, MD & Director||376.12k|
|Mr. Phillip Hains B Bus, C.A., CA, M.B.A., MBA||Company Sec. & CFO||60|
|Mr. Stephen John Carter||Consultant|
|Dr. Richard Franklin||Project Director & Member of Scientific Advisory Board|
|Tony Macintyre||GM & CTO|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Arovella Therapeutics is and its enterprise value is .
Companies similar to Arovella Therapeutics (ALA)
Arovella Therapeutics (ASX:ALA) Frequently Asked Questions
1. What is Arovella Therapeutics's Stock Symbol?
Arovella Therapeutics trades on ASX under the ticker symbol "ALA".
2. What is Arovella Therapeutics's stock price today?
One share of ALA stock can currently be purchased for approximately $0.033.
3. How can I contact Arovella Therapeutics?
Arovella Therapeutics's mailing address is 55 Howe Street Level 1 Unit 12 Osborne Park WA 6017 Australia. The company can be reached via phone at 61 8 6142 5555.
4. What is Arovella Therapeutics's official website?
The official website of Arovella Therapeutics is https://www.arovella.com.
5. Which share registry manages Arovella Therapeutics's stock?
Arovella Therapeutics's stock is managed by AUTOMIC REGISTRY SERVICES.